Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
University of Southern California
City of Hope Medical Center
Eli Lilly and Company
Jonsson Comprehensive Cancer Center
Hoffmann-La Roche
Eli Lilly and Company
Universidad Nacional Autonoma de Mexico
Icahn School of Medicine at Mount Sinai
V.K.V. American Hospital, Istanbul
Vanderbilt-Ingram Cancer Center
Columbia University
Duke University
Delcath Systems Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC